BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1019@pharmaconomics
DTSTAMP:20260707T021632Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:ENGN Approval — detalimogene (estimated date)
DESCRIPTION:A final FDA approval decision on detalimogene for its lead indication is expected ~ Dec 31\, 2028.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1980845/000119312526275815/engn-20260616.htm\n\nTrack it: https://pharmaconomics.com/e/1019
URL:https://pharmaconomics.com/e/1019
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ENGN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR